Skip to content

Comparison of the effects of acupressure points on patients undergoing chemotherapy

Comparison of the effects of acupressure points (P6, K-K9) on Nausea, Vomiting and anxiety of patients undergoing chemotherapy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20100829004655N12
Enrollment
90
Registered
2023-05-04
Start date
2023-05-22
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chemotherapy. Convalescence following chemotherapy

Interventions

Intervention 1: The first intervention group: pressure on the P6 point will be applied bilaterally by acupressure wrist straps. The wristbands are from the vomit-band brand and consist of a webbing wi

Sponsors

Kashan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients 16 years and older Patients with a definitive diagnosis of breast, colorectal, lung, prostate, and ovarian cancers by a specialist doctor Patients who mention having nausea in their previous chemotherapy period Patients who receive chemotherapy drugs by intravenous, port, or intravenous injection along with oral intake Patients who have received at least one cycle of chemotherapy

Exclusion criteria

Exclusion criteria: Undergoing radiotherapy at the same time as chemotherapy Using other complementary treatments at the same time Having a known anxiety disorder Having problems in the skin of acupressure points (for example, edema, lesions, or skin wounds) so that effective pressure cannot be applied Having problems such as gastrointestinal diseases with nausea and vomiting, migraines, and tinnitus that are related to before the start of chemotherapy and interfere with nausea and vomiting of chemotherapy. This case will be reviewed based on the patient's statement or medical record Patients who have a minimal risk of emesis chemotherapy regimen as determined by a specialist doctor.

Design outcomes

Primary

MeasureTime frame
Nausea, whose score is measured by the Rhodes Nausea and Vomiting Questionnaire (statements 4, 5, and 7). Timepoint: One hour after chemotherapy and at the end of the first to fifth days of chemotherapy. Method of measurement: The Rhodes Nausea and Vomiting Questionnaire.;Vomiting, whose score is measured by the Rhodes Nausea and Vomiting Questionnaire (statements 1, 3, and 6). Timepoint: One hour after chemotherapy and at the end of the first to fifth days of chemotherapy. Method of measurement: The Rhodes Nausea and Vomiting Questionnaire.

Secondary

MeasureTime frame
Anxiety is measured by Spielberger's state-trait anxiety questionnaire. Timepoint: One hour after chemotherapy and at the end of the first to fifth days of chemotherapy. Method of measurement: The Spielberger's state-trait anxiety questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohsen Taghadosi

Kashan University of Medical Sciences

taghadosi_m@kaums.ac.ir+98 31 5554 0021

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026